A national survey of Iranian general population to estimate a value set for the EQ-5D-5L

被引:0
作者
Somayeh Afshari
Rajabali Daroudi
Reza Goudarzi
Alireza Mahboub–Ahari
Mehdi Yaseri
Ali Akbari Sari
Hosein Ameri
Sajjad Bahariniya
Alireza Oliaei-Manesh
Khalil Kalavani
Zahra Zare
Elham Hasannezhad
Mohammadamin Mirzaei
Zahra Amiri
机构
[1] Tehran University of Medical Sciences,Department of Health Management, Policy, and Economics, School of Public Health
[2] Kerman University of Medical Sciences,Health Services Management Research Center, Institute for Futures Studies in Health
[3] Tabriz University of Medical Sciences,Iranian Evidence Based Medicine Center, Department of Health Economics
[4] Tehran University of Medical Sciences,Department of Epidemiology and Biostatistics, School of Public Health
[5] Health Policy and Management Research Center,Department of Health Management and Economics, School of Public Health
[6] Shahid Sadoughi University of Medical Sciences,Department of Health Care Management
[7] National Institute for Health Research,Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy
[8] Tehran University of Medical Sciences,Department of Health Management, Policy, and Economics, School of Management and Medical Information Sciences
[9] Shiraz University of Medical Sciences,undefined
[10] Master of Actuarial Science,undefined
[11] ECO College of Insurance,undefined
[12] Allameh Tabatabae′i University,undefined
[13] Tehran University of Medical Sciences,undefined
[14] Kerman University of Medical Sciences,undefined
来源
Quality of Life Research | 2023年 / 32卷
关键词
EQ-5D-5L; Health state valuation; Composite time trade-off; Discrete choice experiment; Iran;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2079 / 2087
页数:8
相关论文
共 181 条
[1]  
Weinstein MC(2009)QALYs: The basics Value In Health 12 S5-S9
[2]  
Torrance G(1996)EuroQol: The current state of play Health Policy 37 53-72
[3]  
McGuire A(2002)The estimation of a preference-based measure of health from the SF-36 Journal of Health Economics 21 271-292
[4]  
Brazier J(2002)Multiattribute and single-attribute utility functions for the health utilities index mark 3 system Medical Care 40 113-128
[5]  
Roberts J(2011)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Quality of Life Research 20 1727-1736
[6]  
Deverill M(2020)Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines The European Journal of Health Economics 21 1245-1257
[7]  
Feeny D(2018)A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D PharmacoEconomics 36 645-661
[8]  
Furlong W(2021)Mapping QLQ-C30 onto EQ-5D-5L and SF-6D-V2 in patients with colorectal and breast cancer from a developing country Value in Health Regional Issues 24 57-66
[9]  
Torrance GW(2022)Utility values in colorectal cancer patients treated with chemotherapy Cancer Investigation 40 46-54
[10]  
Goldsmith CH(2019)Assessing the performance of direct and indirect utility eliciting methods in patients with colorectal cancer: EQ-5D-5L versus C-TTO Health Services and Outcomes Research Methodology 19 259-270